Literature DB >> 10999800

Uniparental disomy in steroid 5alpha-reductase 2 deficiency.

B Chávez1, E Valdez, F Vilchis.   

Abstract

Steroid 5alpha-reductase 2 deficiency is an autosomal recessive form of male pseudohermaphroditism caused by mutations in the SRD5A2 gene. In this study, we performed DNA analyses in two unrelated subjects bearing the enzyme deficiency and found differences in the mode of transmission for the disease. The data showed that in both families the fathers were carriers for an E197D mutation, whereas the mothers were carriers for a P212R mutation. Patient 1 was identified as compound heterozygote because he had both alterations (E197D/P212R). On the contrary, patient 2 was found to be homozygous, but only for the paternal mutation. Because this finding could not be explained on the basis ofnonpaternity or a chromosomal abnormality, the presence of uniparental disomy was suggested. The reduction to homozygosity for the E197D mutation, as confirmed by restriction analysis, supported this view. The results of our study give evidence of the first case of 5alpha-reductase deficiency resulting from uniparental disomy and also disclose an alternate mechanism whereby this enzymatic disorder can derive from a single parent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10999800     DOI: 10.1210/jcem.85.9.6786

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  The ratio of maternal to paternal UPD associated with recessive diseases.

Authors:  Angela M Vianna-Morgante
Journal:  Hum Genet       Date:  2005-05-14       Impact factor: 4.132

2.  Donnai-Barrow syndrome (DBS/FOAR) in a child with a homozygous LRP2 mutation due to complete chromosome 2 paternal isodisomy.

Authors:  Sibel Kantarci; Nicola K Ragge; N Simon Thomas; David O Robinson; Kristin M Noonan; Meaghan K Russell; Dian Donnai; F Lucy Raymond; Christopher A Walsh; Patricia K Donahoe; Barbara R Pober
Journal:  Am J Med Genet A       Date:  2008-07-15       Impact factor: 2.802

Review 3.  Practical approach to steroid 5alpha-reductase type 2 deficiency.

Authors:  Chong Kun Cheon
Journal:  Eur J Pediatr       Date:  2010-03-28       Impact factor: 3.183

4.  Maternal uniparental heterodisomy with partial isodisomy of a chromosome 2 carrying a splice acceptor site mutation (IVS9-2A>T) in ALS2 causes infantile-onset ascending spastic paralysis (IAHSP).

Authors:  Thilo Herzfeld; Nicole Wolf; Pia Winter; Holger Hackstein; Daniel Vater; Ulrich Müller
Journal:  Neurogenetics       Date:  2008-09-23       Impact factor: 2.660

5.  Novel compound heterozygous mutations in the SRD5A2 gene from 46,XY infants with ambiguous external genitalia.

Authors:  Felipe Vilchis; Evangelina Valdez; Luis Ramos; Rocio García; Rita Gómez; Bertha Chávez
Journal:  J Hum Genet       Date:  2008-03-19       Impact factor: 3.172

6.  Inherited surfactant deficiency caused by uniparental disomy of rare mutations in the surfactant protein-B and ATP binding cassette, subfamily a, member 3 genes.

Authors:  Aaron Hamvas; Lawrence M Nogee; Daniel J Wegner; Kelcey Depass; John Christodoulou; Bruce Bennetts; Leon R McQuade; Peter H Gray; Robin R Deterding; Travis R Carroll; Anja Kammesheidt; Laura M Kasch; Shashikant Kulkarni; F Sessions Cole
Journal:  J Pediatr       Date:  2009-08-03       Impact factor: 4.406

Review 7.  Parents of children with autosomal recessive diseases are not always carriers of the respective mutant alleles.

Authors:  Joel Zlotogora
Journal:  Hum Genet       Date:  2004-03-16       Impact factor: 4.132

8.  Primary congenital glaucoma due to paternal uniparental isodisomy of chromosome 2 and CYP1B1 deletion.

Authors:  Emmanuelle Souzeau; Andrew Dubowsky; Jonathan B Ruddle; Jamie E Craig
Journal:  Mol Genet Genomic Med       Date:  2019-06-28       Impact factor: 2.183

Review 9.  Integrative and Analytical Review of the 5-Alpha-Reductase Type 2 Deficiency Worldwide.

Authors:  Rafael Loch Batista; Berenice Bilharinho Mendonca
Journal:  Appl Clin Genet       Date:  2020-04-14

10.  46,XY disorder of sexual development resulting from a novel monoallelic mutation (p.Ser31Phe) in the steroid 5α-reductase type-2 (SRD5A2) gene.

Authors:  Bertha Chávez; Luis Ramos; Rita Gómez; Felipe Vilchis
Journal:  Mol Genet Genomic Med       Date:  2014-03-16       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.